Safety Assessment of an Anti-Obesity Drug (Sibutramine)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety Assessment of an Anti-Obesity Drug (Sibutramine)

Published:2012-08 Issue:8 Volume:35 Page:629-644
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Tyczynski Jerzy E.,Oleske Denise M.,Klingman David,Ferrufino Cheryl P.,Lee Won Chan

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

http://link.springer.com/content/pdf/10.1007/BF03261960.pdf

Reference33 articles.

1. James PT, Rigby N, Leach R. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil Feb 2004; 11(1): 3–8

2. Guh DP, Zhang W, Bansback N, et al. The incidence of comorbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009; 9: 88

3. Padwal RS, Sharma AM. Prevention of cardiovascular disease: obesity, diabetes and the metabolic syndrome. Can J Cardiol 2010 Aug–Sep; 26 Suppl. C: 18–20C

4. Saavedra LE. Endocannabinoid system and cardiometabolic risk. Clin Pharmacol Ther 2007 Nov; 82(5): 591–4

5. Ogden CL, Yanovski SZ, Carroll MD, et al. The epidemiology of obesity. Gastroenterology 2007 May; 132(6): 2087–102

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of hyperbaric oxygen therapy on weight loss and hyperlipidemia in rats;Biochemical and Biophysical Research Communications;2022-04

2. Clinical outcomes associated with anti‐obesity medications in real‐world practice: A systematic literature review;Obesity Reviews;2021-08-22

3. Role of Epidemiology in the Biopharmaceutical Industry;Pharmacovigilance: A Practical Approach;2019

4. Progress and challenges in anti-obesity pharmacotherapy;The Lancet Diabetes & Endocrinology;2018-03

5. Analytical Methodologies for the Stereoselective Determination of Sibutramine: An Overview;Acta Medica Marisiensis;2017-06-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3